This is a very important paper, treating schizophrenia as a neurodegenerative disease and a welcome change from neuroleptics.The effects on ongoing gray matter loss are impressive.
Thompson lab videos on gray matter loss
Powered by Disqus
EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process
Recombinant human erythropoietin a hematopoietic growth factor delays loss of gray matter in chronic schizophrenia
This is a very important paper, treating schizophrenia as a neurodegenerative disease and a welcome change from neuroleptics.The effects on ongoing gray matter loss are impressive.
Thompson lab videos on gray matter loss
Powered by Disqus
This is a very important paper, treating schizophrenia as a neurodegenerative disease and a welcome change from neuroleptics.The effects on ongoing gray matter loss are impressive.
Thompson lab videos on gray matter loss
Powered by Disqus
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment